In-Licensing
Ethypharm is one of the leading European speciality pharmaceutical companies.
We have an active partnering strategy to in-licence products or late stage projects which are driving growth and helping us to strengthen our portfolio.
Ethypharm is one of the leading European speciality pharmaceutical companies.
We have an active partnering strategy to in-licence products or late stage projects which are driving growth and helping us to strengthen our portfolio.
We are strengthening this position and we are expanding nationally and globally. Our Business Development Team is helping us to constantly offer the best products in the areas of Pain, Addiction and Critical Care.
DO YOU HAVE A PROJECT YOU WANT TO DISCUSS WITH US?
Our Business Development Department is always looking at new opportunities and seeks to utilise our in-house capabilities through:
In-licensing
Acquisition of new products
Product development opportunities and collaborations
Global Strategic partnerships and alliances.
PARTNER WITH US!
PLEASE CONTACT information@ethypharm.com FOR MORE INFORMATION ON HOW WE CAN WORK TOGETHER.
England & Wales
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in England & Wales by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.
NHS Prescription Services, part of the NHS Business Services Authority (BSA), is the provider of the England data and NHS Wales Shared Partnerships Services is the provider of the Wales data.
This public sector information is licensed under the Open Government Licence v3.0.
The cost model compares Ethypharm products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.
Scotland
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in Scotland by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.
ISD, NHS Scotland is the provider of the data.
This public sector information is licensed under the Open Government Licence v3.0.
The cost model compares Ethypharm products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.